You have 9 free searches left this month | for more free features.

Leukemia, Eosinophilic, Acute

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in

Completed
  • Childhood Acute Basophilic Leukemia
  • +14 more
  • Phoenix, Arizona
  • +96 more
Jan 20, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

      Completed
      • Leukemia, Acute
        • (no location specified)
        Jul 23, 2023

        Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • CD123 targeted CAR-NK cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Aug 28, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Lyon, France
          Centre Léon Bérard
        Nov 30, 2023

        Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

        Active, not recruiting
        • Relapsed Adult ALL
        • Relapsed Adult AML
        • Changchun, Jilin, China
          First Hospital of Jilin University
        Nov 19, 2023

        H19 in Acute Lymphoblastic Leukemia.

        Not yet recruiting
        • Acute Lymphoid Leukemia
          • (no location specified)
          Jul 11, 2023

          Acute Myeloid Leukemia Trial (ABBV-787)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • (no location specified)
          Sep 29, 2023

          Frequency and Risk Factors of Acute Myeloid Leukemia

          Not yet recruiting
          • Myeloid Leukemia
          • Bone marrow aspirite for diagnosis
          • (no location specified)
          Mar 15, 2023

          B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

          Recruiting
          • B-Cell Lymphoblastic Leukemia
          • Acute Lymphoblastic Leukemia
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2023

          Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Peking University People's Hospital
          Jun 23, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • Acute Lymphoblastic Leukemia With Failed Remission
          • São Paulo, SP, Brazil
            Instituto do Cancer do Estado de Sao Paulo
          Sep 12, 2023

          ALL, Adult, AML, Adult Trial (BN104)

          Not yet recruiting
          • ALL, Adult
          • AML, Adult
          • (no location specified)
          Sep 19, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Oral azacitidine
          • Seoul, Korea, Republic of
            Bristol-Myers Squibb YH
          Oct 3, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • (no location specified)
          May 29, 2023